Page last updated: 2024-10-26

donepezil and Tardive Dystonia

donepezil has been researched along with Tardive Dystonia in 1 studies

Donepezil: An indan and piperidine derivative that acts as a selective and reversible inhibitor of ACETYLCHOLINESTERASE. Donepezil is highly selective for the central nervous system and is used in the management of mild to moderate DEMENTIA in ALZHEIMER DISEASE.
donepezil : A racemate comprising equimolar amounts of (R)- and (S)-donepezil. A centrally acting reversible acetylcholinesterase inhibitor, its main therapeutic use is in the treatment of Alzheimer's disease where it is used to increase cortical acetylcholine.
2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxyindan-1-one : A member of the class of indanones that is 5,6-dimethoxyindan-1-one which is substituted at position 2 by an (N-benzylpiperidin-4-yl)methyl group.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Mimura, Y1
Kurose, S1
Takata, T1
Tabuchi, H1
Mimura, M1
Funayama, M1

Other Studies

1 other study available for donepezil and Tardive Dystonia

ArticleYear
Pisa syndrome induced by switching of a choline-esterase inhibitor treatment from donepezil to galantamine: a case report.
    BMC neurology, 2020, May-13, Volume: 20, Issue:1

    Topics: Alzheimer Disease; Cholinesterase Inhibitors; Donepezil; Female; Galantamine; Humans; Middle Aged; T

2020